Navigation Links
Voices Against Brain Cancer Discusses New Brain Tumor Vaccine HSPPC-96

New York, NY (PRWEB) December 27, 2013

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today that discusses a new brain cancer vaccine called HSPPC-96, which is personally molded to each patient’s genetic makeup.

According to the December 19th article published by Medical News Today titled “Promising results for personalized brain tumor vaccine,” patients with Gliobastoma Multiforme (GBM) brain tumors, when going through standard treatment, have a median survival rate of three to nine months. The new vaccine is developed specifically to each patient using his or her own respected tumor tissue. Investigators say the vaccine works by “prompting an immune system response unique to each patient, which sets out to kill any remaining tumor cells following surgery.”

The article states that 90 percent of patients lived after six months of treatment with this vaccine, while 30 percent lived after one year. However, more research is needed before receiving approval to use this treatment for GBM’s.

Researchers have to determine if the vaccine is safer and more effective when used alongside Avastin, a drug that is standard for therapy against GBM’s and known to reduce tumor size.

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, believes that with more research, this vaccine could be very helpful. “Evidently, additional extensive research has to be done with this vaccine. If results are consistently positive, this vaccine could be a game changer in the treatment of these deadly and aggressive brain tumors,” he says. “Regardless, the fact that this type of treatment is even a possibility, serves as a glimmer of hope for everyone in the brain cancer community.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Neurosurgeons and Nurses
2. Voices Against Brain Cancer Commends Baseball Coach’s Perseverance to Live a Full Life
3. National Voices for Equality, Education and Enlightenment (NVEEE) to Host 3rd Annual “Not on My Watch” VIP Reception Benefiting Bullying and Suicide Prevention Efforts
4. A New Website for Families to Turn: New Health and Wellness Promotion Website Launched by Family Voices
5. Voices Against Brain Cancer Commends 18-Year-Old Brain Cancer Patient for His Positive Outlook and Will to Live
6. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
7. Voices Against Brain Cancer Commends Tech Startup Co-Founder for Positive Outlook Despite Grim Diagnosis
8. Voices Against Brain Cancer Commends Researchers for the Identification of an Important Protein that May Give Insight to More Effective Glioblastoma Treatments
9. Voices Against Brain Cancer Comments On Breakthrough Brain Surgery Technique
10. Redressing Past Wrongs: Changing the Common Rule to Increase Minority Voices in Research
11. Changing the common rule to increase minority voices in research
Post Your Comments:
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, while ... light of the recent terrorist attacks in Paris, other cities are taking extra precautions ... reaching U.S. soil. Especially around special events that may be high-profile in nature, the ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the ... Table 1-1 ). More than 3.7 billion people under the age of 50 ... (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The data ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: